Role of steroid receptor coactivators in glucocorticoid and transforming growth factor β regulation of plasminogen activator inhibitor gene expression

被引:24
作者
Li, GY
Heaton, JH
Gelehrter, TD
机构
[1] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1210/me.2005-0145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TGF beta is a major regulator of extracellular matrix deposition and a potent inducer of type-1 plasminogen activator inhibitor (PAI-1) gene expression. We have reported that liganded glucocorticoid receptor (GR) represses TGF beta transactivation of PAI-1 in Hep3B human hepatoma cells and that it interacts functionally and physically with the C-terminal activation domain of Smad3, a mediator of TGF beta signaling. The ligand binding domain of GR is required for GR-mediated transrepression, but the GR DNA binding domain and activation function 1 domains are not. We report here that overexpression of steroid receptor coactivator-1 (SRC-1) and GR-interacting protein-1 (GRIP-1) enhanced repression by liganded GR, and by a GR mutant defective in repression. Surprisingly, SRC-1 and GRIP-1 also enhanced TGF beta-induced activation from the TGF beta-responsive sequence of the PAI-1 gene by a GR-independent mechanism. Coimmunoprecipitation and mammalian one-hybrid experiments demonstrated that SRC-1 and GRIP-1 interact physically with endogenous Smad3 and functionally with the C-terminal domain of Smad3 to directly enhance transcription. Thus, the GR coactivators, SRC-1 and GRIP-1, act as both corepressors of the glucocorticoid repression of PAI-1 gene transcription, and coactivators of TGF beta-induced activation of the PAI-1 promoter.
引用
收藏
页码:1025 / 1034
页数:10
相关论文
共 49 条
[1]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[2]   Molecular mechanisms of anti-inflammatory action of glucocorticoids [J].
Cato, ACB ;
Wade, E .
BIOESSAYS, 1996, 18 (05) :371-378
[3]   High-pressure synthesis and crystal structures of β-MNX (M = Zr, Hf; X = Cl, Br, I) [J].
Chen, X ;
Koiwasaki, T ;
Yamanaka, S .
JOURNAL OF PHYSICS-CONDENSED MATTER, 2002, 14 (44) :11209-11212
[4]   The androgen receptor represses transforming growth factor-β signaling through interaction with Smad3 [J].
Chipuk, JE ;
Cornelius, SC ;
Pultz, NJ ;
Jorgensen, JS ;
Bonham, MJ ;
Kim, SJ ;
Danielpour, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1240-1248
[5]   Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9 [J].
Cho, SY ;
Kagan, BL ;
Blackford, JA ;
Szapary, D ;
Simons, SS .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (02) :290-311
[6]   Mechanism of a transcriptional cross talk between transforming growth factor-β-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4 [J].
Chou, WC ;
Prokova, V ;
Shiraishi, K ;
Valcourt, U ;
Moustakas, A ;
Hadzopoulou-Cladaras, M ;
Zannis, VI ;
Kardassis, D .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (03) :1279-1294
[7]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356
[8]   Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors [J].
De Bosscher, K ;
Vanden Berghe, W ;
Haegeman, G .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (01) :16-22
[9]   Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a [J].
Giraud, S ;
Bienvenu, F ;
Avril, S ;
Gascan, H ;
Heery, DM ;
Coqueret, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8004-8011
[10]   OPPOSING ACTIONS OF TRANSFORMING GROWTH-FACTOR-BETA AND GLUCOCORTICOIDS IN THE REGULATION OF FIBRONECTIN EXPRESSION IN THE HUMAN PLACENTA [J].
GULLER, S ;
WOZNIAK, R ;
KONG, L ;
LOCKWOOD, CJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3273-3278